24 results on '"O'Rourke, Robert A."'
Search Results
2. The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina.
3. Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System?
4. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
5. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
6. A NON-CLEAVABLE MUTANT OF FAS LIGAND DOES NOT PREVENT NEUTROPHILIC DESTRUCTION OF ISLET TRANSPLANTS1.
7. A DENDRITIC CELL LINE GENETICALLY MODIFIED TO EXPRESS CTLA4-IG AS A MEANS TO PROLONG ISLET ALLOGRAFT SURVIVAL12.
8. Influence of Heart Rate on Left Ventricular Performance in Conscious Dogs.
9. Effect of Alteration of Left Ventricular Activation Sequence on the Left Ventricular End-Systolic Pressure-Volume Relation in Closed-Chest Dogs.
10. Effect of Right Ventricular Pressure on the End- Diastolic Left Ventricular Pressure∗dash;Volume Relationship before and after Chronic Right Ventricular Pressure Overload in Dogs without Pericardia.
11. Evaluation of Left Ventricular Contractile Performance Utilizing End-Systolic Pressure-Volume Relationships in Conscious Dogs.
12. Hemodynamic Effects of a Constant Intravenous Infusion of Piroximone in Patients with Severe Congestive Heart Failure.
13. Hemodynamic Effects of Prolonged Intravenous Therapy with Enoximone in Patients with Severe Congestive Heart Failure.
14. Development of Complement-Fixing 19S, Anti-Heart Mitochondria Autoantibody, Following Myocardial Infarction in Dogs.
15. Choreoathetosis as a manifestation of thyrotoxicosis.
16. Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy.
17. MYOBLASTS ENGINEERED TO EXPRESS TGF-β-1 AND FAS LIGAND CO-TRANSPLANTED WITH MURINE ISLET ALLOGRAFTS DO NOT PREVENT A NEUTROPHILIC INFILTRATE OR PROLONG ALLOGRAFT SURVIVAL.
18. One or Two Doses of Daclizumab Provide Effective Immunosuppression for Renal Transplant Patients with High Immunologic Risk or with Delayed Graft Function.
19. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
20. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
21. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
22. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
23. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina.
24. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.